Polly M Sepulvado, MD | |
573 Ne Stephens St, Roseburg, OR 97470-3150 | |
(541) 677-2432 | |
(541) 957-1131 |
Full Name | Polly M Sepulvado |
---|---|
Gender | Female |
Speciality | Rheumatology |
Experience | 50 Years |
Location | 573 Ne Stephens St, Roseburg, Oregon |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366433781 | NPI | - | NPPES |
005129 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | MD16468 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Medical Center | Roseburg, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Umpqua Community Health Center Inc | 0345233078 | 21 |
News Archive
Scientists from The Scripps Research Institute Florida campus have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output. These new findings could aid future drug design by giving scientists an edge in fine tuning the signal between these partnered proteins—and the drug's course of action.
A group of Canadian and European researchers have unlocked the mystery of a gene with the potential to both regulate and block ovulation.
Conversations between adolescents suffering from chronic illnesses and their families about end-of-life wishes well before a serious event occurs won't discourage hope for recovery or cause additional emotional or mental harm to young patients, according to new research from Children's National Medical Center and St. Jude Children's Research Hospital published in the journal Pediatrics.
BioScrip, Inc. announced 2010 second quarter revenue of $412.0 million, operating income of $13.5 million and net income of $3.1 million, or $0.06 per diluted share. Second quarter adjusted earnings per share (detailed in schedule 5) was $0.07 per diluted share. Adjusted EBITDA for the quarter was $18.4 million. All 2010 per share amounts have been adjusted to reflect the Company's issuance of 13.1 million shares in conjunction with the acquisition of CHS.
For men, a heart attack increases the risk of dying from coronary heart disease more than diabetes does, but for women, diabetes is sometimes the greater threat, according to a new study (PDF) in the May 3, 2005, issue of the Journal of the American College of Cardiology.
› Verified 9 days ago
Entity Name | Umpqua Community Health Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396751772 PECOS PAC ID: 0345233078 Enrollment ID: O20040511000463 |
News Archive
Scientists from The Scripps Research Institute Florida campus have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output. These new findings could aid future drug design by giving scientists an edge in fine tuning the signal between these partnered proteins—and the drug's course of action.
A group of Canadian and European researchers have unlocked the mystery of a gene with the potential to both regulate and block ovulation.
Conversations between adolescents suffering from chronic illnesses and their families about end-of-life wishes well before a serious event occurs won't discourage hope for recovery or cause additional emotional or mental harm to young patients, according to new research from Children's National Medical Center and St. Jude Children's Research Hospital published in the journal Pediatrics.
BioScrip, Inc. announced 2010 second quarter revenue of $412.0 million, operating income of $13.5 million and net income of $3.1 million, or $0.06 per diluted share. Second quarter adjusted earnings per share (detailed in schedule 5) was $0.07 per diluted share. Adjusted EBITDA for the quarter was $18.4 million. All 2010 per share amounts have been adjusted to reflect the Company's issuance of 13.1 million shares in conjunction with the acquisition of CHS.
For men, a heart attack increases the risk of dying from coronary heart disease more than diabetes does, but for women, diabetes is sometimes the greater threat, according to a new study (PDF) in the May 3, 2005, issue of the Journal of the American College of Cardiology.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Polly M Sepulvado, MD 573 Ne Stephens St, Roseburg, OR 97470-3150 Ph: (541) 677-2432 | Polly M Sepulvado, MD 573 Ne Stephens St, Roseburg, OR 97470-3150 Ph: (541) 677-2432 |
News Archive
Scientists from The Scripps Research Institute Florida campus have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output. These new findings could aid future drug design by giving scientists an edge in fine tuning the signal between these partnered proteins—and the drug's course of action.
A group of Canadian and European researchers have unlocked the mystery of a gene with the potential to both regulate and block ovulation.
Conversations between adolescents suffering from chronic illnesses and their families about end-of-life wishes well before a serious event occurs won't discourage hope for recovery or cause additional emotional or mental harm to young patients, according to new research from Children's National Medical Center and St. Jude Children's Research Hospital published in the journal Pediatrics.
BioScrip, Inc. announced 2010 second quarter revenue of $412.0 million, operating income of $13.5 million and net income of $3.1 million, or $0.06 per diluted share. Second quarter adjusted earnings per share (detailed in schedule 5) was $0.07 per diluted share. Adjusted EBITDA for the quarter was $18.4 million. All 2010 per share amounts have been adjusted to reflect the Company's issuance of 13.1 million shares in conjunction with the acquisition of CHS.
For men, a heart attack increases the risk of dying from coronary heart disease more than diabetes does, but for women, diabetes is sometimes the greater threat, according to a new study (PDF) in the May 3, 2005, issue of the Journal of the American College of Cardiology.
› Verified 9 days ago
Dr. Neil Kumar, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2410 Nw Edenbower Blvd Ste 176, Roseburg, OR 97471 Phone: 541-957-1133 Fax: 541-957-1799 | |
Bhanu Prasad Paladugu, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2700 Nw Stewart Pkwy, Roseburg, OR 97470 Phone: 561-677-1773 Fax: 541-677-1794 | |
Kurt A Brickner, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1813 W Harvard Ave, Suite 241, Roseburg, OR 97471 Phone: 541-673-5579 Fax: 541-673-0576 | |
Dr. Luul - Ghebrednghil, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 913 Nw Garden Valley Blvd, Roseburg, OR 97470 Phone: 541-440-1000 Fax: 541-440-1344 | |
Dr. Alpana Chandra, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2460 Nw Stewart Parkway, Suite 103, Roseburg, OR 97471 Phone: 541-672-9515 Fax: 541-464-3177 | |
Siobhan A Oreilly, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 272 Medical Loop, Suite B, Roseburg, OR 97471 Phone: 541-464-5400 Fax: 541-464-5411 | |
Harold F Anderson, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1813 W Harvard Ave, Suite 201, Roseburg, OR 97470 Phone: 541-440-6390 Fax: 541-440-6392 |